aluates Reports

$ 0.0

Automative

Global Polio Vaccine Market Research Report 2026

Published Date: 2026-02-06

Report Code: QYRE-Auto-18B4237

Global Polio Vaccine Market Research Report 2021

BUY CHAPTERS

Global Polio Vaccine Market Research Report 2026

Code: QYRE-Auto-18B4237

Report

2026-02-06

Pages:114

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sanofi

GSK

Bibcol

Serum Institute

Tiantan biological

IMBCA

Panacea Biotec Ltd

Bio-Med

Halfkin Bio-Pharmaceuticals

Polio Vaccine Market Size

The global Polio Vaccine market was valued at US$ 799 million in 2025 and is anticipated to reach US$ 1062 million by 2032, at a CAGR of 4.2% from 2026 to 2032.

Polio Vaccine Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Polio Vaccine competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.

The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2016.

Sanofi, GSK and Serum Institute are the top 3 players of Polio Vaccine with about 91% market shares.

This report delivers a comprehensive overview of the global Polio Vaccine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Polio Vaccine. The Polio Vaccine market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Polio Vaccine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Polio Vaccine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Polio Vaccine Market Report

Report Metric	Details
Report Name	Polio Vaccine Market
Accounted market size in 2025	US$ 799 million
Forecasted market size in 2032	US$ 1062 million
CAGR	4.2%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Inactivated Polio Vaccine (IPV) Oral Polio Vaccine (OPV)
by Application	Public Private
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Polio Vaccine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Polio Vaccine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Polio Vaccine Market growing?

Ans: The Polio Vaccine Market witnessing a CAGR of 4.2% during the forecast period 2026-2032.

What is the Polio Vaccine Market size in 2032?

Ans: The Polio Vaccine Market size in 2032 will be US$ 1062 million.

What is the market share of major companies in Polio Vaccine Market?

Ans: Sanofi, GSK and Serum Institute are the top 3 players of Polio Vaccine with about 91% market shares.

Who are the main players in the Polio Vaccine Market report?

Ans: The main players in the Polio Vaccine Market are Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals

What are the Application segmentation covered in the Polio Vaccine Market report?

Ans: The Applications covered in the Polio Vaccine Market report are Public, Private

What are the Type segmentation covered in the Polio Vaccine Market report?

Ans: The Types covered in the Polio Vaccine Market report are Inactivated Polio Vaccine (IPV), Oral Polio Vaccine (OPV)

1 Polio Vaccine Market Overview

1.1 Product Definition

1.2 Polio Vaccine by Type

1.2.1 Global Polio Vaccine Market Value by Type: 2025 vs 2032

1.2.2 Inactivated Polio Vaccine (IPV)

1.2.3 Oral Polio Vaccine (OPV)

1.3 Polio Vaccine by Application

1.3.1 Global Polio Vaccine Market Value by Application: 2025 vs 2032

1.3.2 Public

1.3.3 Private

1.4 Global Polio Vaccine Market Size Estimates and Forecasts

1.4.1 Global Polio Vaccine Revenue 2021–2032

1.4.2 Global Polio Vaccine Sales 2021–2032

1.4.3 Global Polio Vaccine Market Average Price (2021–2032)

1.5 Assumptions and Limitations

2 Polio Vaccine Market Competition by Manufacturers

2.1 Global Polio Vaccine Sales Market Share by Manufacturers (2021–2026)

2.2 Global Polio Vaccine Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Polio Vaccine Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Polio Vaccine, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Polio Vaccine, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Polio Vaccine, Product Types and Applications

2.7 Global Key Manufacturers of Polio Vaccine, Date of Entry into the Industry

2.8 Global Polio Vaccine Market Competitive Situation and Trends

2.8.1 Global Polio Vaccine Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Polio Vaccine Players Market Share by Revenue

2.8.3 Global Polio Vaccine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Polio Vaccine Market Scenario by Region

3.1 Global Polio Vaccine Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Polio Vaccine Sales by Region: 2021–2032

3.2.1 Global Polio Vaccine Sales by Region: 2021–2026

3.2.2 Global Polio Vaccine Sales by Region: 2027–2032

3.3 Global Polio Vaccine Revenue by Region: 2021–2032

3.3.1 Global Polio Vaccine Revenue by Region: 2021–2026

3.3.2 Global Polio Vaccine Revenue by Region: 2027–2032

3.4 North America Polio Vaccine Market Facts & Figures by Country

3.4.1 North America Polio Vaccine Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Polio Vaccine Sales by Country (2021–2032)

3.4.3 North America Polio Vaccine Revenue by Country (2021–2032)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Polio Vaccine Market Facts & Figures by Country

3.5.1 Europe Polio Vaccine Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Polio Vaccine Sales by Country (2021–2032)

3.5.3 Europe Polio Vaccine Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Polio Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific Polio Vaccine Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Polio Vaccine Sales by Region (2021–2032)

3.6.3 Asia Pacific Polio Vaccine Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Polio Vaccine Market Facts & Figures by Country

3.7.1 Latin America Polio Vaccine Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Polio Vaccine Sales by Country (2021–2032)

3.7.3 Latin America Polio Vaccine Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Polio Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Polio Vaccine Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Polio Vaccine Sales by Country (2021–2032)

3.8.3 Middle East and Africa Polio Vaccine Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Polio Vaccine Sales by Type (2021–2032)

4.1.1 Global Polio Vaccine Sales by Type (2021–2026)

4.1.2 Global Polio Vaccine Sales by Type (2027–2032)

4.1.3 Global Polio Vaccine Sales Market Share by Type (2021–2032)

4.2 Global Polio Vaccine Revenue by Type (2021–2032)

4.2.1 Global Polio Vaccine Revenue by Type (2021–2026)

4.2.2 Global Polio Vaccine Revenue by Type (2027–2032)

4.2.3 Global Polio Vaccine Revenue Market Share by Type (2021–2032)

4.3 Global Polio Vaccine Price by Type (2021–2032)

5 Segment by Application

5.1 Global Polio Vaccine Sales by Application (2021–2032)

5.1.1 Global Polio Vaccine Sales by Application (2021–2026)

5.1.2 Global Polio Vaccine Sales by Application (2027–2032)

5.1.3 Global Polio Vaccine Sales Market Share by Application (2021–2032)

5.2 Global Polio Vaccine Revenue by Application (2021–2032)

5.2.1 Global Polio Vaccine Revenue by Application (2021–2026)

5.2.2 Global Polio Vaccine Revenue by Application (2027–2032)

5.2.3 Global Polio Vaccine Revenue Market Share by Application (2021–2032)

5.3 Global Polio Vaccine Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Sanofi

6.1.1 Sanofi Company Information

6.1.2 Sanofi Description and Business Overview

6.1.3 Sanofi Polio Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Sanofi Polio Vaccine Product Portfolio

6.1.5 Sanofi Recent Developments/Updates

6.2 GSK

6.2.1 GSK Company Information

6.2.2 GSK Description and Business Overview

6.2.3 GSK Polio Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 GSK Polio Vaccine Product Portfolio

6.2.5 GSK Recent Developments/Updates

6.3 Bibcol

6.3.1 Bibcol Company Information

6.3.2 Bibcol Description and Business Overview

6.3.3 Bibcol Polio Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Bibcol Polio Vaccine Product Portfolio

6.3.5 Bibcol Recent Developments/Updates

6.4 Serum Institute

6.4.1 Serum Institute Company Information

6.4.2 Serum Institute Description and Business Overview

6.4.3 Serum Institute Polio Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Serum Institute Polio Vaccine Product Portfolio

6.4.5 Serum Institute Recent Developments/Updates

6.5 Tiantan Biological

6.5.1 Tiantan Biological Company Information

6.5.2 Tiantan Biological Description and Business Overview

6.5.3 Tiantan Biological Polio Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Tiantan Biological Polio Vaccine Product Portfolio

6.5.5 Tiantan Biological Recent Developments/Updates

6.6 IMBCA

6.6.1 IMBCA Company Information

6.6.2 IMBCA Description and Business Overview

6.6.3 IMBCA Polio Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 IMBCA Polio Vaccine Product Portfolio

6.6.5 IMBCA Recent Developments/Updates

6.7 Panacea Biotec Ltd

6.7.1 Panacea Biotec Ltd Company Information

6.7.2 Panacea Biotec Ltd Description and Business Overview

6.7.3 Panacea Biotec Ltd Polio Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Panacea Biotec Ltd Polio Vaccine Product Portfolio

6.7.5 Panacea Biotec Ltd Recent Developments/Updates

6.8 Bio-Med

6.8.1 Bio-Med Company Information

6.8.2 Bio-Med Description and Business Overview

6.8.3 Bio-Med Polio Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Bio-Med Polio Vaccine Product Portfolio

6.8.5 Bio-Med Recent Developments/Updates

6.9 Halfkin Bio-Pharmaceuticals

6.9.1 Halfkin Bio-Pharmaceuticals Company Information

6.9.2 Halfkin Bio-Pharmaceuticals Description and Business Overview

6.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 Halfkin Bio-Pharmaceuticals Polio Vaccine Product Portfolio

6.9.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Polio Vaccine Industry Chain Analysis

7.2 Polio Vaccine Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Polio Vaccine Production Mode & Process Analysis

7.4 Polio Vaccine Sales and Marketing

7.4.1 Polio Vaccine Sales Channels

7.4.2 Polio Vaccine Distributors

7.5 Polio Vaccine Customer Analysis

8 Polio Vaccine Market Dynamics

8.1 Polio Vaccine Industry Trends

8.2 Polio Vaccine Market Drivers

8.3 Polio Vaccine Market Challenges

8.4 Polio Vaccine Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Sanofi

GSK

Bibcol

Serum Institute

Tiantan biological

IMBCA

Panacea Biotec Ltd

Bio-Med

Halfkin Bio-Pharmaceuticals

List of Tables

Table 1. Global Polio Vaccine Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Polio Vaccine Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global Polio Vaccine Market Competitive Situation by Manufacturers in 2025

Table 4. Global Polio Vaccine Sales (K Units) of Key Manufacturers (2021–2026)

Table 5. Global Polio Vaccine Sales Market Share by Manufacturers (2021–2026)

Table 6. Global Polio Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)

Table 7. Global Polio Vaccine Revenue Share by Manufacturers (2021–2026)

Table 8. Global Market Polio Vaccine Average Price (USD/Unit) of Key Manufacturers (2021–2026)

Table 9. Global Key Players of Polio Vaccine, Industry Ranking, 2023 vs 2024 vs 2025

Table 10. Global Key Manufacturers of Polio Vaccine, Manufacturing Sites and Headquarters

Table 11. Global Key Manufacturers of Polio Vaccine, Product Types and Applications

Table 12. Global Key Manufacturers of Polio Vaccine, Date of Entry into the Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Polio Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Polio Vaccine Revenue, 2025

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Polio Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 17. Global Polio Vaccine Sales by Region (K Units), 2021–2026

Table 18. Global Polio Vaccine Sales Market Share by Region (2021–2026)

Table 19. Global Polio Vaccine Sales by Region (K Units), 2027–2032

Table 20. Global Polio Vaccine Sales Market Share by Region (2027–2032)

Table 21. Global Polio Vaccine Revenue by Region (US$ Million), 2021–2026

Table 22. Global Polio Vaccine Revenue Market Share by Region (2021–2026)

Table 23. Global Polio Vaccine Revenue by Region (US$ Million), 2027–2032

Table 24. Global Polio Vaccine Revenue Market Share by Region (2027–2032)

Table 25. North America Polio Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 26. North America Polio Vaccine Sales by Country (K Units), 2021–2026

Table 27. North America Polio Vaccine Sales by Country (K Units), 2027–2032

Table 28. North America Polio Vaccine Revenue by Country (US$ Million), 2021–2026

Table 29. North America Polio Vaccine Revenue by Country (US$ Million), 2027–2032

Table 30. Europe Polio Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 31. Europe Polio Vaccine Sales by Country (K Units), 2021–2026

Table 32. Europe Polio Vaccine Sales by Country (K Units), 2027–2032

Table 33. Europe Polio Vaccine Revenue by Country (US$ Million), 2021–2026

Table 34. Europe Polio Vaccine Revenue by Country (US$ Million), 2027–2032

Table 35. Asia Pacific Polio Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 36. Asia Pacific Polio Vaccine Sales by Region (K Units), 2021–2026

Table 37. Asia Pacific Polio Vaccine Sales by Region (K Units), 2027–2032

Table 38. Asia Pacific Polio Vaccine Revenue by Region (US$ Million), 2021–2026

Table 39. Asia Pacific Polio Vaccine Revenue by Region (US$ Million), 2027–2032

Table 40. Latin America Polio Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 41. Latin America Polio Vaccine Sales by Country (K Units), 2021–2026

Table 42. Latin America Polio Vaccine Sales by Country (K Units), 2027–2032

Table 43. Latin America Polio Vaccine Revenue by Country (US$ Million), 2021–2026

Table 44. Latin America Polio Vaccine Revenue by Country (US$ Million), 2027–2032

Table 45. Middle East and Africa Polio Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 46. Middle East and Africa Polio Vaccine Sales by Country (K Units), 2021–2026

Table 47. Middle East and Africa Polio Vaccine Sales by Country (K Units), 2027–2032

Table 48. Middle East and Africa Polio Vaccine Revenue by Country (US$ Million), 2021–2026

Table 49. Middle East and Africa Polio Vaccine Revenue by Country (US$ Million), 2027–2032

Table 50. Global Polio Vaccine Sales (K Units) by Type (2021–2026)

Table 51. Global Polio Vaccine Sales (K Units) by Type (2027–2032)

Table 52. Global Polio Vaccine Sales Market Share by Type (2021–2026)

Table 53. Global Polio Vaccine Sales Market Share by Type (2027–2032)

Table 54. Global Polio Vaccine Revenue (US$ Million) by Type (2021–2026)

Table 55. Global Polio Vaccine Revenue (US$ Million) by Type (2027–2032)

Table 56. Global Polio Vaccine Revenue Market Share by Type (2021–2026)

Table 57. Global Polio Vaccine Revenue Market Share by Type (2027–2032)

Table 58. Global Polio Vaccine Price (USD/Unit) by Type (2021–2026)

Table 59. Global Polio Vaccine Price (USD/Unit) by Type (2027–2032)

Table 60. Global Polio Vaccine Sales (K Units) by Application (2021–2026)

Table 61. Global Polio Vaccine Sales (K Units) by Application (2027–2032)

Table 62. Global Polio Vaccine Sales Market Share by Application (2021–2026)

Table 63. Global Polio Vaccine Sales Market Share by Application (2027–2032)

Table 64. Global Polio Vaccine Revenue (US$ Million) by Application (2021–2026)

Table 65. Global Polio Vaccine Revenue (US$ Million) by Application (2027–2032)

Table 66. Global Polio Vaccine Revenue Market Share by Application (2021–2026)

Table 67. Global Polio Vaccine Revenue Market Share by Application (2027–2032)

Table 68. Global Polio Vaccine Price (USD/Unit) by Application (2021–2026)

Table 69. Global Polio Vaccine Price (USD/Unit) by Application (2027–2032)

Table 70. Sanofi Company Information

Table 71. Sanofi Description and Business Overview

Table 72. Sanofi Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 73. Sanofi Polio Vaccine Product

Table 74. Sanofi Recent Developments/Updates

Table 75. GSK Company Information

Table 76. GSK Description and Business Overview

Table 77. GSK Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 78. GSK Polio Vaccine Product

Table 79. GSK Recent Developments/Updates

Table 80. Bibcol Company Information

Table 81. Bibcol Description and Business Overview

Table 82. Bibcol Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 83. Bibcol Polio Vaccine Product

Table 84. Bibcol Recent Developments/Updates

Table 85. Serum Institute Company Information

Table 86. Serum Institute Description and Business Overview

Table 87. Serum Institute Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 88. Serum Institute Polio Vaccine Product

Table 89. Serum Institute Recent Developments/Updates

Table 90. Tiantan Biological Company Information

Table 91. Tiantan Biological Description and Business Overview

Table 92. Tiantan Biological Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 93. Tiantan Biological Polio Vaccine Product

Table 94. Tiantan Biological Recent Developments/Updates

Table 95. IMBCA Company Information

Table 96. IMBCA Description and Business Overview

Table 97. IMBCA Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 98. IMBCA Polio Vaccine Product

Table 99. IMBCA Recent Developments/Updates

Table 100. Panacea Biotec Ltd Company Information

Table 101. Panacea Biotec Ltd Description and Business Overview

Table 102. Panacea Biotec Ltd Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 103. Panacea Biotec Ltd Polio Vaccine Product

Table 104. Panacea Biotec Ltd Recent Developments/Updates

Table 105. Bio-Med Company Information

Table 106. Bio-Med Description and Business Overview

Table 107. Bio-Med Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 108. Bio-Med Polio Vaccine Product

Table 109. Bio-Med Recent Developments/Updates

Table 110. Halfkin Bio-Pharmaceuticals Company Information

Table 111. Halfkin Bio-Pharmaceuticals Description and Business Overview

Table 112. Halfkin Bio-Pharmaceuticals Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 113. Halfkin Bio-Pharmaceuticals Polio Vaccine Product

Table 114. Halfkin Bio-Pharmaceuticals Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Polio Vaccine Distributors List

Table 118. Polio Vaccine Customers List

Table 119. Polio Vaccine Market Trends

Table 120. Polio Vaccine Market Drivers

Table 121. Polio Vaccine Market Challenges

Table 122. Polio Vaccine Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of Polio Vaccine

Figure 2. Global Polio Vaccine Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Polio Vaccine Market Share by Type: 2025 & 2032

Figure 4. Inactivated Polio Vaccine (IPV) Product Picture

Figure 5. Oral Polio Vaccine (OPV) Product Picture

Figure 6. Global Polio Vaccine Market Value by Application (US$ Million), 2021–2032

Figure 7. Global Polio Vaccine Market Share by Application: 2025 & 2032

Figure 8. Public

Figure 9. Private

Figure 10. Global Polio Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 11. Global Polio Vaccine Market Size (US$ Million), 2021–2032

Figure 12. Global Polio Vaccine Sales (K Units), 2021–2032

Figure 13. Global Polio Vaccine Average Price (USD/Unit), 2021–2032

Figure 14. Polio Vaccine Report Years Considered

Figure 15. Polio Vaccine Sales Share by Manufacturers in 2025

Figure 16. Global Polio Vaccine Revenue Share by Manufacturers in 2025

Figure 17. Top 5 and Top 10 Global Polio Vaccine Players: Market Share by Revenue in Polio Vaccine in 2025

Figure 18. Polio Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 19. Global Polio Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 20. North America Polio Vaccine Sales Market Share by Country (2021–2032)

Figure 21. North America Polio Vaccine Revenue Market Share by Country (2021–2032)

Figure 22. U.S. Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 23. Canada Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 24. Europe Polio Vaccine Sales Market Share by Country (2021–2032)

Figure 25. Europe Polio Vaccine Revenue Market Share by Country (2021–2032)

Figure 26. Germany Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 27. France Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 28. U.K. Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 29. Italy Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 30. Russia Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 31. Asia Pacific Polio Vaccine Sales Market Share by Region (2021–2032)

Figure 32. Asia Pacific Polio Vaccine Revenue Market Share by Region (2021–2032)

Figure 33. China Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 34. Japan Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. South Korea Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. India Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. Australia Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. Taiwan Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. Indonesia Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. Thailand Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Malaysia Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. Philippines Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. Latin America Polio Vaccine Sales Market Share by Country (2021–2032)

Figure 44. Latin America Polio Vaccine Revenue Market Share by Country (2021–2032)

Figure 45. Mexico Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Brazil Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. Argentina Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. Middle East and Africa Polio Vaccine Sales Market Share by Country (2021–2032)

Figure 49. Middle East and Africa Polio Vaccine Revenue Market Share by Country (2021–2032)

Figure 50. Turkey Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Saudi Arabia Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. U.A.E Polio Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 53. Global Sales Market Share of Polio Vaccine by Type (2021–2032)

Figure 54. Global Revenue Market Share of Polio Vaccine by Type (2021–2032)

Figure 55. Global Polio Vaccine Price (USD/Unit) by Type (2021–2032)

Figure 56. Global Sales Market Share of Polio Vaccine by Application (2021–2032)

Figure 57. Global Revenue Market Share of Polio Vaccine by Application (2021–2032)

Figure 58. Global Polio Vaccine Price (USD/Unit) by Application (2021–2032)

Figure 59. Polio Vaccine Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Poliomyelitis Vaccine Market Research Report 2025

Poliovirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Polio Vaccination Market Research Report 2025

Inactivated Poliovirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Inactivated Polio Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Inactivated Polio Virus Vaccine Market Research Report 2025

Poliovirus Vaccine Inactivated Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Combined Polio Vaccine Market Research Report 2024

Global Live Attenuated Polio Vaccine Market Research Report 2024

Global Poliomyelitis Vaccine in Dragee Candy Market Research Report 2025

Global Vaccines For Children Market Insights Forecast to 2030

Global Oral Polio Vaccines OPV Market Research Report 2024

Disease Control and Prevention Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Rotavirus Vaccines Market Insights Forecast to 2030

Mono Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sabin Inactivated Polio vaccine sIPV Market Research Report 2025

Combination Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Inactivated Polio and Rabies Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global DTaP and Tdap Vaccines Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions